Taylor Inglis

Destiny Bioscience Global Corp. engages in cannabis genetics and tissue culture research and development. It combines high throughput genomics-based breeding techniques with organic cultivation techniques, to supply true-to-type certified pest and disease-free cannabis clones, and true cannabis-derived pharmaceutical-grade products. The company was founded by Ed Moroz and is headquartered in Nisku, Canada.